EFFECT OF AN ACE-INHIBITOR (ENALAPRIL) OR AN ANGIOTENSIN-II RECEPTOR ANTAGONIST ON INTERSTITIAL VOLUME AND MACROPHAGE INFILTRATION OF THE OBSTRUCTED KIDNEY

被引：0
|
作者：
MORRISSEY, J [1 ]
KANETO, H [1 ]
KLAHR, S [1 ]
机构：
[1] WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,ST LOUIS,MO 63110
来源：
CLINICAL RESEARCH | 1994年 / 42卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A219 / A219
页数：1
相关论文
共 50 条
  • [31] EFFECT OF AN ANGIOTENSIN-II AND A KININ RECEPTOR ANTAGONIST ON THE RENAL HEMODYNAMIC-RESPONSE TO CAPTOPRIL
    FENOY, FJ
    SCICLI, G
    CARRETERO, O
    ROMAN, RJ
    HYPERTENSION, 1991, 17 (06) : 1038 - 1044
  • [32] Effect of an ACE-inhibitor (enalapril) on the activity of antioxidant enzymes and H2O2 production in rat remnant kidney cortex
    VandenBranden, C
    DeCraemer, D
    Peeters, P
    VandenHoute, K
    Verbeelen, D
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (06) : 794 - 794
  • [33] HYPOTENSIVE EFFECT OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ESSENTIAL-HYPERTENSION
    TSUNODA, K
    ABE, K
    HAGINO, T
    OMATA, K
    MISAWA, S
    IMAI, Y
    YOSHINAGA, K
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (01) : 28 - 32
  • [34] EFFECT OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON RESPONSE OF CORTISOL AND ALDOSTERONE TO ADRENOCORTICOTROPIC HORMONE
    SASAKI, M
    FUJIMURA, A
    HARADA, K
    SUNAGA, K
    EBIHARA, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (08): : 776 - 779
  • [35] Effects of the angiotensin receptor antagonist candesartan and the ACE inhibitor enalapril on ultrasound markers of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy
    Ciulla, MM
    Pallotti, R
    Esposito, A
    Cuspidi, C
    Muiesan, ML
    Salvetti, M
    Agabiti-Rosei, E
    Magrini, F
    Zanchetti, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S381 - S381
  • [36] COMPARISON OF THE ANGIOTENSIN-II ANTAGONIST UP269-6 WITH THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL IN NORMOTENSIVE VOLUNTEERS CHALLENGED WITH ANGIOTENSIN-I
    INGLESSIS, N
    NUSSBERGER, J
    HAGMANN, M
    HIESSEPROVOST, O
    INSUASTY, J
    REID, J
    MENARD, J
    BRUNNER, HR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (06) : 986 - 993
  • [37] Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: Effects of an ACE inhibitor and an angiotensin II receptor antagonist
    Kakizawa, H
    Itoh, Y
    Imamura, S
    Matsumoto, T
    Ishiwata, Y
    Ono, Y
    Yamamoto, K
    Kato, T
    Hayakawa, N
    Oda, N
    Goto, Y
    Nagasaka, A
    Senda, T
    Itoh, M
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) : 458 - 464
  • [38] COMPARISON OF ENALAPRIL (E) AND ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST ON ALBUMINURIA (UALB V) IN RATS WITH PASSIVE HEYMANN NEPHRITIS (PHN)
    HUTCHISON, FN
    WEBSTER, SK
    CLINICAL RESEARCH, 1991, 39 (02): : A358 - A358
  • [39] ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with Diabetes MellitusAre They Underutilized?
    Lamioko Shika Pappoe
    Wolfgang C. Winkelmayer
    Drugs & Aging, 2010, 27 : 87 - 94
  • [40] ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with Diabetes Mellitus Are They Underutilized?
    Pappoe, Lamioko Shika
    Winkelmayer, Wolfgang C.
    DRUGS & AGING, 2010, 27 (02) : 87 - 94
12345